Literature DB >> 19390768

A case of late adult-onset dentatorubral-pallidoluysian atrophy mimicking central pontine myelinolysis.

Junpei Kobayashi, Masahiro Nagao, Akihiro Kawata, Siro Matsubara.   

Abstract

We report the case of a 52-year-old man with late-onset dentatorubral-pallidoluysian atrophy (DRPLA). MRI findings of late-onset DRPLA usually showed the involvement of cerebral white matter lesions with high intensity on T2-weighted images (WI), in addition to brainstem, globus pallidus, and thalamus. But our patient did not present with abnormal manifestation of white matter lesions of the cerebrum. In addition, the appearance of pontine base was remarkably similar to central pontine myelinolysis (CPM). There is no reported case of DRPLA mimicking CPM in the literature, while there is one previous report of CPM with cerebellar ataxia without pyramidal tract involvement, and CPM may exhibit cerebellar ataxia. Although there is differentiation between CPM and DRPLA by the presence of the atrophy of brainstem and cerebellum, the characteristic MRI findings of pontine base may make it difficult to differentiate CPM with cerebellar ataxia from DRPLA with inconspicuous leukoencephalopathy. In such a situation, we should return to the clinical history and background of a patient, and, if necessary, DNA analysis should be performed for a definite diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19390768     DOI: 10.1007/s00415-009-5111-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

1.  Central pontine myelinolysis.

Authors:  N A Pirzada; I I Ali
Journal:  Mayo Clin Proc       Date:  2001-05       Impact factor: 7.616

2.  Central pontine myelinolysis at autopsy; a twelve year retrospective analysis.

Authors:  K L Newell; B K Kleinschmidt-DeMasters
Journal:  J Neurol Sci       Date:  1996-10       Impact factor: 3.181

3.  Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings.

Authors:  R Koide; O Onodera; T Ikeuchi; R Kondo; H Tanaka; S Tokiguchi; A Tomoda; T Miike; F Isa; H Beppu; N Shimizu; Y Watanabe; Y Horikawa; T Shimohata; K Hirota; A Ishikawa; S Tsuji
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

4.  Fluid attenuation inversion recovery (FLAIR) images of dentatorubropallidoluysian atrophy: case report.

Authors:  F Yoshii; H Tomiyasu; Y Shinohara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

5.  Dentatorubral pallidoluysian atrophy in South Wales.

Authors:  M Wardle; E Majounie; N M Williams; A E Rosser; H R Morris; N P Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-10-26       Impact factor: 10.154

6.  Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).

Authors:  R Koide; T Ikeuchi; O Onodera; H Tanaka; S Igarashi; K Endo; H Takahashi; R Kondo; A Ishikawa; T Hayashi
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

7.  Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat.

Authors:  T Ikeuchi; R Koide; H Tanaka; O Onodera; S Igarashi; H Takahashi; R Kondo; A Ishikawa; A Tomoda; T Miike
Journal:  Ann Neurol       Date:  1995-06       Impact factor: 10.422

  7 in total
  4 in total

1.  Is cerebral white matter involvement helpful in the diagnosis of dentatorubral-pallidoluysian atrophy?

Authors:  Won Tae Yoon; Jinyoung Youn; Jin Whan Cho
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

2.  Radiologic and neuropathologic findings in patients in a family with dentatorubral-pallidoluysian atrophy.

Authors:  Y Sunami; R Koide; N Arai; M Yamada; T Mizutani; K Oyanagi
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

Review 3.  Dentatorubral-pallidoluysian Atrophy: An Update.

Authors:  Liam S Carroll; Thomas H Massey; Mark Wardle; Kathryn J Peall
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-10-01

4.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.